Kevin Rakin

Kevin Rakin is a co-founder and partner at HighCape Partners, a growth equity life sciences fund. Previously he was the president of Regenerative Medicine at Shire plc, a leading specialty biopharmaceutical company. Prior to joining Shire, Mr. Rakin served as chairman and CEO of Advanced BioHealing (ABH) from 2007 until its acquisition by Shire in June 2011. Before this, he served as the interim CEO of ABH and executive-in-residence at Canaan Partners. Previously, he was a co-founder, president and chief executive officer of Genaissance Pharmaceuticals Inc., a publicly held pharmacogenomics company, until its merger with Clinical Data Inc. in October 2005.

He serves as chairman of Cheetah Medical Inc. and Aziyo Biologics Inc. and as a board member of CyBrexa Inc., Histogenics Corp. and TELA Bio Inc. Mr. Rakin holds an MBA from Columbia University and received B.Com and B.Com (Hons) degrees from the University of Cape Town, South Africa.